Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases. This has led to the discovery of common pathophysiological pathways such as enhanced oxidative stress, protein misfolding and aggregation and dysfunction of the ubiquitin-proteasome system. Here, we describe loss-of-function mutations in a previously uncharacterized, predominantly neuronal P-type ATPase gene, ATP13A2, underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia (PARK9, Kufor-Rakeb syndrome). Whereas the wild-type protein was located in the lysosome of transiently transfected cells, the unstable truncated mutants were retained in the endoplasmic reticulum and degraded by the proteasome. Our findings link a class of proteins with unknown function and substrate specificity to the protein networks implicated in neurodegeneration and parkinsonism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar phenotype has also been described in the context of loss‐of‐function mutations in the P‐type ATPase gene ATP13A2, in which recessive, early‐onset PD has been linked to defective acidification of lysosomes and insufficient autophagy (Ramirez et al, 2006).”
From Autophagy in major human diseases (2021) · cites this paper as Ramirez et al, 2006
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“By mutation screening or linkage analysis, we excluded the known autosomal recessive Parkinson disease genes and loci: PARK2 (also known as Parkin ; ref”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., Lightfoot, S., Menzel, W., Granzow, M., & Ragg, T. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-3 · Cited by 2,623
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Proteolysis: from the lysosome to ubiquitin and the proteasome
Ciechanover, A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1552 · Cited by 1,133
Evolution of Substrate Specificities in the P-Type ATPase Superfamily
Axelsen, K. B., & Palmgren, M. G. (1998) · Journal of Molecular Evolution · doi:10.1007/pl00006286 · Cited by 910
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Cited by
Items 601–700 of 1,000
Leucine‐rich repeat kinase 2 and lysosomal dyshomeostasis in Parkinson disease
Cogo, S., Manzoni, C., Lewis, P. A., & Greggio, E. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14908 · Cited by 27
The Mechanism of Physical Activity-induced Amelioration of Parkinson’s Disease: A Narrative Review
Gronek, P., Haas, A. N., Czarny, W., Podstawski, R., Delabary, M. D. S., Clark, C. C. T., Boraczyński, M., Tarnas, M., Wycichowska, P., Pawlaczyk, M., et al. (2021) · Aging and Disease · doi:10.14336/ad.2020.0407 · Cited by 32
Disrupted myelination network in the cingulate cortex of Parkinson's disease
Xie, S., Yang, J., Huang, S., Fan, Y., Xu, T., He, J., Guo, J., Ji, X., Wang, Z., Li, P., et al. (2022) · IET Systems Biology · doi:10.1049/syb2.12043 · Cited by 27
Piscopo, P., Manzini, V., Rivabene, R., Crestini, A., Pera, L. L., Pizzi, E., Veroni, C., Talarico, G., Peconi, M., Castellano, A. E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113232 · Cited by 28
P5-ATPases: Structure, substrate specificities, and transport mechanisms
Sim, S. I., & Park, E. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102531 · Cited by 28
Genetic Evidence for Endolysosomal Dysfunction in Parkinson’s Disease: A Critical Overview
Yahya, V., Fonzo, A. D., & Monfrini, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076338 · Cited by 27
Greiner-Tollersrud, O. K., & Berg, T. (2007) · Springer eBooks · doi:10.1007/0-387-28957-7_6 · Cited by 28
Genetics of Parkinson’s Disease - A Clinical Perspective
Cheon, S., Chan, L., Chan, D. K. Y., & Kim, J. W. (2012) · Journal of Movement Disorders · doi:10.14802/jmd.12009 · Cited by 31
Young‐onset parkinsonism due to homozygous duplication of α‐synuclein in a consanguineous family
Kojović, M., Sheerin, U., Rubio‐Agusti, I., Saha, R. A., Brás, J., Gibbons, V., Palmer, R. W., Houlden, H., Hardy, J., Wood, N. W., et al. (2012) · Movement Disorders · doi:10.1002/mds.25199 · Cited by 27
A novel X‐linked four‐repeat tauopathy with Parkinsonism and spasticity
Poorkaj, P., Raskind, W. H., Leverenz, J. B., Matsushita, M., Zabetian, C. P., Samii, A., Kim, S., Gazi, N., Nutt, J. G., Wolff, J., et al. (2010) · Movement Disorders · doi:10.1002/mds.23085 · Cited by 27
Myhre, R., Steinkjer, S., Stormyr, A., Nilsen, G. L., Zayyad, H., Horany, K., Nusier, M. K., & Klungland, H. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-47 · Cited by 29
‘Atypical’ Parkinson's disease – genetic
Weißbach, A., Wittke, C., Kasten, M., & Klein, C. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.011 · Cited by 28
Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine
Watanabe, H., Hattori, T., Kume, A., Misu, K., Ito, T., Koike, Y., Johnson, T. A., Kamitsuji, S., Kamatani, N., & Sobue, G. (2020) · Medicine · doi:10.1097/md.0000000000021576 · Cited by 28
Juvenile parkinsonism associated with heterozygous frameshift ATP13A2 gene mutation
Fong, C. Y., Rolfs, A., Schwarzbraun, T., Klein, C., & O'Callaghan, F. J. (2011) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2011.01.001 · Cited by 27
What lysosomes actually tell us about Parkinson’s disease?
Bourdenx, M., & Dehay, B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.02.008 · Cited by 26
Alberio, T., & Fasano, M. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.08.004 · Cited by 30
ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology
Dang, T., Cao, W.-J., Zhao, R., Lu, M., Hu, G., & Qiao, C. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220001 · Cited by 26
What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
Fernández‐Santiago, R., & Sharma, M. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101648 · Cited by 28
Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson’s Disease
Sanchez-Mirasierra, I., Ghimire, S., Hernández-Díaz, S., & Soukup, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.921314 · Cited by 26
Conformational cycle of human polyamine transporter ATP13A2
Mu, J., Xue, C., Fu, L., Yu, Z., Nie, M., Wu, M., Chen, X., Liu, K., Bu, R., Huang, Y. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37741-0 · Cited by 27
Current trends in basic research on Parkinson’s disease: from mitochondria, lysosome to α-synuclein
Matsui, H., & Takahashi, R. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02774-2 · Cited by 27
Yong-Kee, C. J., Salomonczyk, D., & Nash, J. E. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9174-2 · Cited by 28
Cellular models of Batten disease
Minnis, C. J., Thornton, C. D., FitzPatrick, L. M., & McKay, T. R. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165559 · Cited by 29
Clinical and genetic analysis of ATP13A2 in hereditary spastic paraplegia expands the phenotype
Estiar, M. A., Léveillé, E., Spiegelman, D., Dupré, N., Trempe, J., Rouleau, G. A., & Gan‐Or, Z. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1052 · Cited by 26
Currim, F., Singh, J., Shinde, A., Gohel, D., Roy, M., Singh, K., Shukla, S., Mane, M., Vasiyani, H., & Singh, R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02243-3 · Cited by 28
P-type transport ATPases inLeishmaniaandTrypanosoma
Meade, J. C. (2019) · Parasite · doi:10.1051/parasite/2019069 · Cited by 25
Liu, X., Cheng, R., Ye, X., Verbitsky, M., Kisselev, S., Mejia‐Santana, H., Louis, E. D., COTE, L. J., Andrews, H., Waters, C., et al. (2013) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.18 · Cited by 25
Genetic Identification in Early Onset Parkinsonism among Norwegian Patients
Gustavsson, E. K., Trinh, J., McKenzie, M. B., Bortnick, S., Petersen, M. S., Farrer, M. J., & Aasly, J. O. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12501 · Cited by 25
Whole‐exome sequencing for variant discovery in blepharospasm
Tian, J., Vemula, S. R., Xiao, J., Valente, E. M., Defazio, G., Petrucci, S., Gigante, A. F., Rudzińska, M., Wszołek, Z. K., Kennelly, K. D., et al. (2018) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.411 · Cited by 25
Khalil, H. W., Chahine, L. M., Siddiqui, J., Salari, M., El-Jaafary, S. I., Aldaajani, Z., Al‐Melh, M. A., Mohammad, T. M., Snineh, M. A., Syed, N. A., et al. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191751 · Cited by 27
ATP13A2 variability in Taiwanese Parkinson's disease
Chen, C., Lin, C., Juan, H., Hu, F.-J., Hsiao, Y.-C., Chang, H., Chao, C., Chen, I., Lee, L., Wang, T., et al. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31214 · Cited by 25
Bridging the age spectrum of neurodegenerative storage diseases
Boland, B., & Platt, F. M. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.08.009 · Cited by 26
GIGYF2 mutations are not a frequent cause of familial Parkinson's disease
Fonzo, A. D., Fabrizio, E., Thomas, A., Fincati, E., Marconi, R., Tinazzi, M., Breedveld, G. J., Simons, E. J., Chien, H. F., Ferreira, J. J., et al. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.05.001 · Cited by 25
Chew, E. G. Y., Liu, Z., Li, Z., Chung, S. J., Lian, M. M., Tandiono, M., Heng, Y. J., Ng, E., Tan, L. C. S., Chng, W. L., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00760-7 · Cited by 27
The pallidopyramidal syndromes: nosology, aetiology and pathogenesis
Kara, E., Hardy, J., & Houlden, H. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283632e83 · Cited by 25
Parkinson's Disease: From Genetics to Clinical Practice
Clarimón, J., & Kulisevsky, J. (2014) · Current Genomics · doi:10.2174/1389202914666131210212305 · Cited by 27
Hyun, C. H., Yoon, C. Y., Lee, H.-J., & Lee, S. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.4.249 · Cited by 27
Emerging preclinical pharmacological targets for Parkinson's disease
More, S. V., & Choi, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8104 · Cited by 26
Neurotoxic and Neuroprotective Role of Exosomes in Parkinson’s Disease
Longoni, B., Fasciani, I., Kolachalam, S., Pietrantoni, I., Marampon, F., Petragnano, F., Aloisi, G., Coppolino, M. F., Rossi, M., Scarselli, M., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191113103537 · Cited by 25
Huber, R. J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00653-y · Cited by 28
Johnson, M., Bergkvist, L., Stetzik, L. A., Steiner, J. A., Meyerdirk, L. K., Schulz, E., Wolfrum, E., Luk, K. C., Wesson, D. W., Krainc, D., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105513 · Cited by 26
dos Santos, A. V., Pestana, C. P., Diniz, K. R. D. S., Campos, M., Abdalla, C. B., de Rosso, A. L. Z., Pereira, J. S., Nicaretta, D. H., de Carvalho, W. L., dos Santos, J. M., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.083 · Cited by 26
Tian, J., Tang, B., Shi, C., Lv, Z., Li, K., Yu, R.-L., Shen, L. H., Yan, X., & Guo, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.078 · Cited by 24
Medaka Fish Parkinson's Disease Model
Matsui, H., Gavinio, R., & Takahashi, R. (2012) · Experimental Neurobiology · doi:10.5607/en.2012.21.3.94 · Cited by 27
Gaucher and Parkinson diseases: Unexpectedly related
Rogaeva, E. A., & Hardy, J. (2008) · Neurology · doi:10.1212/01.wnl.0000314657.92762.0f · Cited by 24
Parkinson’s disease pathogenesis from the viewpoint of small fish models
Matsui, H., & Takahashi, R. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1772-1 · Cited by 23
Kaur, S., Sehrawat, A., Mastana, S. S., Kandimalla, R. J. L., Sharma, P. K., Bhatti, G. K., & Bhatti, J. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121995 · Cited by 25
Regulation of LRRK2 promoter activity and gene expression by Sp1
Wang, J., & Song, W. (2016) · Molecular Brain · doi:10.1186/s13041-016-0215-5 · Cited by 26
Dirr, E. R., Ekhator, O. R., Blackwood, R., Holden, J. G., Masliah, E., Schultheis, P. J., & Fleming, S. M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.029 · Cited by 23
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies
Paciotti, S., Gatticchi, L., Beccari, T., & Parnetti, L. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.03.1627 · Cited by 26
The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis
Marcos, A., Corradi, G. R., Mazzitelli, L. R., Casali, C. I., Tome, M. C. F., Adamo, H. P., & Pinto, F. D. T. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.05.015 · Cited by 24
Francelle, L., & Mazzulli, J. R. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147798 · Cited by 23
Application of serial analysis of gene expression to the study of human genetic disease
Horan, M. P. (2009) · Human Genetics · doi:10.1007/s00439-009-0719-5 · Cited by 23
Developmental expression of P5 ATPase mRNA in the mouse
Weingarten, L. S., Dave, H., Li, H., & Crawford, D. A. (2011) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-011-0039-3 · Cited by 23
The neuronal ceroid-lipofuscinoses (Batten disease)
Mole, S., Schulz, A., & Haltia, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00004-7 · Cited by 23
GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population
Meeus, B., Nuytemans, K., Crosiers, D., Engelborghs, S., Pals, P., Pickut, B. A., Peeters, K., Mattheijssens, M., Corsmit, E., Cras, P. P., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.016 · Cited by 23
The intertwined relationship between circadian dysfunction and Parkinson's disease
Duret, L. C., & Nagoshi, E. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.10.006 · Cited by 22
Lu, J., Florio, D. N. D., Boya, P., Maday, S., Springer, W., & Chu, C. T. (2025) · Autophagy · doi:10.1080/15548627.2025.2581217 · Cited by 25
Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
Vermeiren, Y., Hirschberg, Y., Mertens, I., & Deyn, P. P. D. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00595 · Cited by 22
Sikora, J., Doveró, S., Kinet, R., Arotçarena, M.-L., Bohic, S., Bézard, E., Fernagut, P., & Dehay, B. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00757-4 · Cited by 22
Parkinson's Disease: From Genetics to Treatments
Fan, H., Chen, S., Harn, H., & Lin, S. (2013) · Cell Transplantation · doi:10.3727/096368912x655082 · Cited by 26
hling, T. M. ⁄., Duda, J., Weishaupt, J. H., Ludolph, A. C., & Liss, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00353 · Cited by 23
Self-citationSoste, M., Charmpi, K., Lampert, F., Gerez, J., van Oostrum, M., Malinovska, L., Boersema, P. J., Prymaczok, N. C., Riek, R., Peter, M., et al. (2019) · Cell Systems · doi:10.1016/j.cels.2019.07.010 · Cited by 22
A genetic analysis of a Spanish population with early onset Parkinson’s disease
Tejera‐Parrado, C., Mir, P., Teresa, P. M., Vela, L., Abreu‐Rodríguez, I., Cánovas, A. A., Bernal‐Bernal, I., Bonilla‐Toribio, M., Buiza‐Rueda, D., José, C. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238098 · Cited by 23
Loss of ATP13A2 impairs glycolytic function in Kufor-Rakeb syndrome patient-derived cell models
Park, J., Koentjoro, B., Davis, R. L., & Sue, C. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.018 · Cited by 22
Efficient GSH delivery using PAMAM-GSH into MPP-induced PC12 cellular model for Parkinson’s disease
Sun, H., Wang, Y., Hao, T., Wang, C., Wang, Q., & Jiang, X. (2016) · Regenerative Biomaterials · doi:10.1093/rb/rbw032 · Cited by 22
GIGYF2 Asn56Ser and Asn457Thr mutations in Parkinson disease patients
Guo, Y., Jankovic, J. J., Zhu, S., Le, W., Song, Z. J., Xie, W., Liao, D., Yang, H., & Deng, H. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.039 · Cited by 22
Manecka, D.-L., Vanderperre, B., Fon, E. A., & Durcan, T. M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00311 · Cited by 21
“CMA-mediated degradation of α-syn and LRRK2 is also impaired by mutants of these proteins that cause inherited PD (A53T and A30P α-syn mutants; G2019S and R1441C LRRK2 mutants).”
BackgroundInfluentialNBIA Syndromes: A Step Forward from the Previous Knowledge
Svetel, M. V., Dragašević, N., Petrović, I. N., Novaković, I. V., Tomić, A., Kresojević, N. D., Stanković, I., & Kostić, V. (2021) · Neurology India · doi:10.4103/0028-3886.329603 · Cited by 21
Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches
Huang, Y. M., Wei, J., Cooper, A. A., & Morris, M. J. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.015 · Cited by 22
Role of Autophagy in Parkinson’s Disease
Grace, G. Y., Zhang, C., & Lim, K. (2013) · InTech eBooks · doi:10.5772/54927 · Cited by 22
Bae, N.-Y., Chung, S., Kim, H., Cha, J. W., Oh, H., Gu, M., Oh, M. S., & Yang, H. O. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.11.007 · Cited by 22
Iron Pathophysiology in Neurodegeneration with Brain Iron Accumulation
Levi, S., Cozzi, A., & Santambrogio, P. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_9 · Cited by 21
Molecular and clinical insights into protein misfolding and associated amyloidosis
Pande, M., & Srivastava, R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111753 · Cited by 21
ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson’s Disease Model
Gao, H., Sun, H., Yan, N., Zhao, P., Xu, H. J., Zheng, W., Zhang, X., Wang, T., Guo, C., & Zhong, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23148035 · Cited by 26
Papa, S., Sardanelli, A. M., Capitanio, N., & Piccoli, C. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9252-4 · Cited by 22
Corradi, G. R., Pinto, F. D. T., Mazzitelli, L. R., & Adamo, H. P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363465 · Cited by 21
Hauser, D. N., Primiani, C. T., & Cookson, M. (2016) · Current Protein and Peptide Science · doi:10.2174/1389203717666160311121954 · Cited by 22
The memory- and cognition-facilitating effects of spermidine in aging and aging-related disorders
Zou, M., Li, D., & Yang, Y. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102787 · Cited by 23
Unlocking the brain’s zinc code: implications for cognitive function and disease
Sabouri, S., Rostamirad, M., & Dempski, R. E. (2024) · Frontiers in Biophysics · doi:10.3389/frbis.2024.1406868 · Cited by 21
Unraveling the Triad: Hypoxia, Oxidative Stress and Inflammation in Neurodegenerative Disorders
Dakal, T. C., Choudhary, K., Tiwari, I., Yadav, V., Maurya, P. K., & Sharma, N. K. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.06.021 · Cited by 21
Erb, M. L., Sipple, K., Levine, N. D., Chen, X., & Moore, D. J. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00748-5 · Cited by 22
Update on neurodegeneration with brain iron accumulation
Popławska-Domaszewicz, K., Florczak‐Wyspianska, J., & Kozubski, W. P. (2014) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2014.05.001 · Cited by 20
Kaur, I., Behl, T., Sehgal, A., Singh, S., Sharma, N., Aleya, L., & BUNGAU, S. G. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14619-6 · Cited by 20
Genetic variations of Omi/HTRA2 in Chinese patients with Parkinson's disease
Wang, C., Xu, Q., Weng, L., Zhang, Q., Zhang, H., Guo, J., Tan, L., Tang, J., Yan, X., & Tang, B. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.037 · Cited by 20
Robinson, P. A. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.40 · Cited by 22
Clinical implications of gene discovery in Parkinson's disease and parkinsonism
Wider, C. W., Foroud, T., & Wszołek, Z. K. (2010) · Movement Disorders · doi:10.1002/mds.22723 · Cited by 22
Kelm‐Nelson, C. A., Stevenson, S. A., & Ciucci, M. R. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.003 · Cited by 26
Non-synonymous GIGYF2 variants in Parkinson’s disease from two Asian populations
Tan, E., Lin, C.-H., Tai, C., Tan, L. C. S., Chen, M., Li, R., Lim, H., Ratnagopal, P., Yih, Y., Prakash, K. M., et al. (2009) · Human Genetics · doi:10.1007/s00439-009-0678-x · Cited by 20
Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System
Hegde, A. N., Timm, L. E., Sivley, C. J., Ramiyaramcharankarthic, S., Lowrimore, O. J., Hendrix, B. J., Grozdanov, T. G., & Anderson, W. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030966 · Cited by 19
Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases
Izco, M., Carlos, E., & Alvarez‐Erviti, L. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105651 · Cited by 19
Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?
Checler, F., & da Costa, C. A. (2022) · Biomolecules · doi:10.3390/biom12040559 · Cited by 19
Ca2+ Induces Spontaneous Dephosphorylation of a Novel P5A-type ATPase
Sørensen, D. M., Møller, A. B., Jakobsen, M. K., Jensen, M. K., Vangheluwe, P., Buch-Pedersen, M. J., & Palmgren, M. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.387191 · Cited by 19
Modeling LRRK2 Pathobiology in Parkinson’s Disease: From Yeast to Rodents
Daniel, G., & Moore, D. J. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_311 · Cited by 21
Action Myoclonus and Seizure in Kufor‐Rakeb Syndrome
Rohani, M., Lang, A. E., Sina, F., Elahi, E., Fasano, A. A., Hardy, J., Brás, J., & Alavi, A. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12570 · Cited by 19
ATP13A2 novel mutations causing a rare form of juvenile-onset Parkinson disease
Suleiman, J., Hamwi, N., & El‐Hattab, A. W. (2018) · Brain and Development · doi:10.1016/j.braindev.2018.05.017 · Cited by 19
Neurodegeneration with Brain Iron Accumulation and a Brief Report of the Disease in Iran
Hajati, R., Emamikhah, M., Fard, F. D., Rohani, M., & Alavi, A. (2021) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2021.124 · Cited by 19
Ito, K., Araki, M., Katai, Y., Nishimura, Y., Imotani, S., Inoue, H., Ito, G., & Tomita, T. (2023) · The FASEB Journal · doi:10.1096/fj.202200780rr · Cited by 21
Exploring the Pathogenetic Mechanisms underlying Parkinson's Disease in Medaka Fish
Matsui, H., Uemura, N., Yamakado, H., Takeda, S., & Takahashi, R. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130289 · Cited by 21
Schneider, S. A., Zorzi, G. S., & Nardocci, N. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0254-5 · Cited by 21
Metadata
- Authors
- Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., Al-Din, A., Hillmer, A. M., Karsak, M., Liss, B., Woods, C. G., Behrens, M. I., & Kubisch, C.
- Affiliations
- University of Cologne (DE)
- Philipps University of Marburg (DE)
- University of Leeds (GB)
- Centro de Estudios Científicos (CL)
- University of Bonn (DE)
- King Hussein Medical Center (JO)
- Pinderfields Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Kubisch, Christian
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-09-10
- Volume
- 38
- Issue
- 10
- Pages
- 1184-1191
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2139369185
- Cited by
- 1,208
- References
- 30
- Citations by year
- 2026: 42 · 2025: 44 · 2024: 39 · 2023: 49 · 2022: 45 · 2021: 70 · 2020: 73 · 2019: 69 · 2018: 54 · 2017: 64 · 2016: 76 · 2015: 59 · 2014: 57 · 2013: 71 · 2012: 64
- FWCI
- 38.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion)
- Funders
- Tinker Foundation
- Wellcome Trust
- Royal Society
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Rheinische Friedrich-Wilhelms-Universität Bonn
- National Institutes of Health
- Directorate for Biological Sciences
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- ATP13A2, P-type ATPase, Kufor-Rakeb syndrome, PARK9, autosomal recessive inheritance, loss-of-function mutations, neurodegeneration, endoplasmic reticulum retention, proteasomal degradation, protein misfolding
- MeSH terms
- Adenosine Triphosphatases, Dementia, Endoplasmic Reticulum, Female, Proton-Translocating ATPases, Humans, Lysosomes, Male, Mesencephalon, Mutation, Neurons, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.